Exercise throughout chemotherapy reduces cognitive impairment, inflammation
the ONA take:
According to a study presented at the 2015 American Society of Clinical Oncology annual meeting this week, researchers from the University of Rochester have found that patients with cancer who exercise throughout chemotherapy had reduced chronic inflammation and cognitive impairment.
For the phase III study, researchers enrolled 619 patients with early-stage cancer. Participants were randomly assigned to receive standard care (no prescribed exercise during chemotherapy) or a specialized program labelled EXCAP. Patients in the EXCAP group walked daily and used resistance bands as instructed while also wearing a pedometer to track steps walked.
Results showed that patients in the standard care group experienced reduced mobility and increased brain fogginess and memory problems. Those patients also had higher levels of blood inflammation. Subgroup analyses showed patients who received chemotherapy in 2-week cycles experienced the most benefit from EXCAP.
"To think that a very simple, low-cost, self-directed exercise prescription can create an anti-inflammatory response similar to a drug and protect against cognitive decline in people with cancer is innovative and very exciting," said Karen M. Mustian, PhD, MPH, associate professor in the University of Rochester Departments of Surgery and Radiation Oncology.
Patients with cancer who exercise throughout chemotherapy had reduced chronic inflammation and cognitive impairment.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|